Page 3 - Embecta Corp News Today

Keeley Teton Advisors LLC trimmed its position in Embecta Corp. (NASDAQ:EMBC – Free Report) by 11.2% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 164,351 shares of the company’s stock after selling 20,632 shares during the quarter. Keeley Teton Advisors LLC owned approximately […]

Embecta (NASDAQ:EMBC – Get Free Report) and Tenon Medical (NASDAQ:TNON – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, dividends, institutional ownership, earnings, analyst recommendations, valuation and risk. Valuation and Earnings This table compares Embecta and […]

PARSIPPANY, N.J., Jan. 24, 2024 (GLOBE NEWSWIRE) -- Embecta Corp. ("embecta") (NASDAQ:EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, will host a conference call to discuss its fiscal

In this article, we will take a detailed look at the 16 Most Profitable New Stocks Today. For a quick overview of such stocks, read our article 5 Most Profitable New Stocks Today. IPO activity showed some signs of a rebound in 2023 but public markets are far from the enthusiasm witnessed in 2021. Some notable IPOs in 2023 […]

IPO activity showed some signs of a rebound in 2023 but public markets are far from the enthusiasm witnessed in 2021. Some notable IPOs in 2023 included those of ARM, Instacart, Klaviyo, among others.

Presenter SpeechCaroline Borowski Hi all. My name is Caroline Borowski, and Im part of the healthcare investment banking group here at JPMorgan. It is my pleasure to introduce Dev Kurdikar, the CEO;...

PARSIPPANY, N.J., Jan. 09, 2024 (GLOBE NEWSWIRE) -- Embecta Corp. ("embecta") EMBC, a global diabetes care company with a 100-year legacy in insulin delivery,…

Pen Needles Market Market Growth 2024 To 2032:The growth of the global pen needles market is driven by multiple factors, including an increase in the prevalence of chronic conditions, a surge in awareness and adoption of injector pens, and advantages offered by pen needles over traditional syringes. The rising preva...

Embecta (NASDAQ:EMBC – Get Free Report) and Teleflex (NYSE:TFX – Get Free Report) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their institutional ownership, risk, valuation, analyst recommendations, dividends, earnings and profitability. Earnings & Valuation This table compares Embecta and Teleflex’s top-line […]

Embecta Corp. (NASDAQ:EMBC – Get Free Report) was the target of a large increase in short interest in the month of November. As of November 15th, there was short interest totalling 3,330,000 shares, an increase of 6.7% from the October 31st total of 3,120,000 shares. Currently, 5.9% of the shares of the company are short […]